bioAffinity Technologies Inc Sustainability Reports
The company addresses the unmet need for non-invasive, early-stage cancer diagnosis and treatment by developing proprietary in-vitro diagnostic tests and targeted therapeutics.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2024 to 2024
Company Profile
The company addresses the unmet need for non-invasive, early-stage cancer diagnosis and treatment by developing proprietary in-vitro diagnostic tests and targeted therapeutics.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
